RxDoctor Payments Data

Emily Landrum, MD

Family Medicine · Starkville, MSNPI 1639550783

Payments from drug & device makers

$632in general payments, 2019–2025

Across 28 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$310
  • Edwards Lifesciences$81
  • Organon$54
  • AstraZeneca$31
  • Dexcom, Inc.$21
  • Sanofi Pasteur Inc.$20
  • plus $114 from 7 others

What the payments were for

  • Food & beverage$632100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$632 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$159,939
Medicare patients
394
Services billed
2,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$119,351
EliquisApixaban107$78,008
JardianceEmpagliflozin53$64,645
FarxigaDapagliflozin Propanediol69$46,143
TrulicityDulaglutide32$40,157
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$32,343
RybelsusSemaglutide16$22,909
JanuviaSitagliptin Phosphate11$17,980
EntrestoSacubitril/Valsartan11$16,590
Tresiba Flextouch U-200Insulin Degludec12$10,403
MyrbetriqMirabegron12$9,071
SynthroidLevothyroxine Sodium94$7,037
LinzessLinaclotide13$6,916
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$6,053
Breo ElliptaFluticasone/Vilanterol11$5,838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$78,008107 claims
AstraZenecaFarxiga, Symbicort$31$49,54182 claims
Lilly USA, LLCTrulicity$12$40,15732 claims
GSKTrelegy Ellipta, Breo Ellipta$13$38,18145 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Starkville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →